Keyword: Cipla

News

Teva Wins US Nod for Allergan’s Generics

29.07.2016 - Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...

News

Roche Wins Patent Dispute Against Cipla

11.12.2015 - An Indian court has unexpectedly sided with Swiss drugmaker Roche in a long-running patent dispute with Indian generics giant Cipla. A two-judge panel for the Delhi High Court...

Markets & Companies

Potential In Eastern Europe

29.07.2014 - Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...

News

Indian Pharma Industry Trends

25.09.2013 - The India Brand Equity Foundation (IBEF) has released an overview of the current trends in the Indian pharmaceutical market. The domestic pharmaceutical industry in India has been...

News

Indian Companies to Policymakers: Shape up, or we’ll ship out

09.09.2013 - After the rapid slide in India's rupee this year, the message from the country's corporate titans to the government is clear: shape up and fix the problems or more companies will...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Cipla to Bid $215 Million for Control of South Africa Affiliate

21.11.2012 - Indian drugmaker Cipla plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic...